Reddit Posts
The Future of BioTech? Axim Biotechnologies, Inc. (OTCQB: $AXIM)
(OTCQB: $AXIM) Axim Biotechnologies, Inc. {DD}
Brief Overview of Axim Biotechnologies, Inc. (OTCQB: $AXIM)
Brief Overview of Axim Biotechnologies, Inc. (OTCQB: $AXIM)
Brief Overview of Axim Biotechnologies, Inc. (OTCQB: $AXIM)
Brief Overview of Axim Biotechnologies, Inc. (OTCQB: $AXIM)
Brief Overview of Axim Biotechnologies, Inc. (OTCQB: $AXIM)
Brief Overview of Axim Biotechnologies, Inc. (OTCQB: $AXIM)
Brief Overview of Axim Biotechnologies, Inc. (OTCQB: $AXIM)
Brief Overview of Axim Biotechnologies, Inc. (OTCQB: $AXIM)
Mentions
AXIM Biotechnologies, Inc. (OTC: AXIM) (the "Company") today announced a strategic alliance with Medical Marijuana, Inc. (OTC: MJNA) intended to research and develop applications and uses for AXIM's patent for water soluble cannabinoids. At the center of the transactions entered into between the Company and MJNA is AXIM's U.S. Patent No. 11,542,226 B2, Polyfunctional Cannabinoids (the "Patent"). AXIM assigned to MJNA a fifty percent (50%) right, title, and economic interest in the Patent and all associated intellectual property. The assignment includes rights to: Existing and future U.S. and foreign patents and applications Licensing, enforcement, and monetization proceeds Claims for past infringement and accrued royalties Concurrently, with the Patent assignment, AXIM and MJNA entered into a Consulting Agreement, whereby the Company will provide MJNA with research and development services focused on researching and developing applications and uses for the Patent technology. Skip to main content Yahoo Finance Yahoo Finance Sign in Search query Search for news or tickers This is a paid press release. Contact the press release distributor directly with any inquiries. NewMediaWire AXIM Biotechnologies, Inc. and Medical Marijuana, Inc. Enter Into Strategic Alliance to Research and Develop Applications and Uses of Patent for Water Soluble Cannabinoids NewMediaWire · AXIM Biotech NewMediaWire Thu, January 29, 2026 at 6:00 AM PST 4 min read In this article: AXIM +2.05% MJNA +50.00% Customers Don’t Mind AI—When It Works Custom Content from WSJ | Twilio • Ad SAN DIEGO, CA - January 29, 2026 (NEWMEDIAWIRE) - AXIM Biotechnologies, Inc. (OTC: AXIM) (the "Company") today announced a strategic alliance with Medical Marijuana, Inc. (OTC: MJNA) intended to research and develop applications and uses for AXIM's patent for water soluble cannabinoids. At the center of the transactions entered into between the Company and MJNA is AXIM's U.S. Patent No. 11,542,226 B2, Polyfunctional Cannabinoids (the "Patent"). AXIM assigned to MJNA a fifty percent (50%) right, title, and economic interest in the Patent and all associated intellectual property. The assignment includes rights to: Existing and future U.S. and foreign patents and applications Licensing, enforcement, and monetization proceeds Claims for past infringement and accrued royalties Concurrently, with the Patent assignment, AXIM and MJNA entered into a Consulting Agreement, whereby the Company will provide MJNA with research and development services focused on researching and developing applications and uses for the Patent technology. Catalina Valenica, AXIM President, in commenting on the transactions stated: "This alliance with MJNA presents both companies with the ability to accelerate uses of the Patent technology. The water solubility of CBD and other cannabinoids is a significant development for the improved administration and increased potency of cannabinoids. We believe that the Patent could result in the development of a drug or treatment, most likely in the form of sublingual administration, able to treat a variety of conditions including anxiety or seizures. We are very excited about this new partnership and the potential it can unlock for our respective companies." Dr. Scott, MJNA Chairman and President, stated: "We have tremendous confidence in the AXIM team's ability to provide R&D support for the development of commercialized uses of the Patent technology. The potential for developing enhanced administration of water soluble CBD and other cannabinoids for certain ailments and conditions is a major development for MJNA. In addition, MJNA already has significant knowledge and exposure to the cannabinoid market and enjoys relationships in that arena. We think that this alliance is a great fit, with tremendous opportunity for both MJNA and AXIM."
also AXIM, I bought in 2017 $700, that one is worth less than 2 bucks now. All my weed positions have been ruined. I did mess with Sundial, but got out after taking profit. I have some CRLBF which I'm doing DCA, Probably best to invest in MSOS rather than a specific stock
I am a bot from /r/wallstreetbets. You submitted one or more banned tickers: AXIM. Message /u/zjz if they're above 500 million-ish market cap and not related to crypto/pennies/OTC.
I am a bot from /r/wallstreetbets. You submitted one or more banned tickers: AXIM. Message /u/zjz if they're above 500 million-ish market cap and not related to crypto/pennies/OTC.